RSV604, a novel inhibitor of respiratory syncytial virus replication (Q36094843)

12 August 2017

RSV604, a novel inhibitor of respiratory syncytial virus replication (English)

1 reference

respiratory syncytial virus

12 August 2017

0 references

pharmacology

0 references

author name string

Joanna Chapman

1

1 reference

12 August 2017

Elizabeth Abbott

2

1 reference

12 August 2017

Dagmar G Alber

3

1 reference

12 August 2017

Robert C Baxter

4

1 reference

12 August 2017

Sian K Bithell

5

1 reference

12 August 2017

Elisa A Henderson

6

1 reference

12 August 2017

Malcolm C Carter

7

1 reference

12 August 2017

Phil Chambers

8

1 reference

12 August 2017

Ann Chubb

9

1 reference

12 August 2017

G Stuart Cockerill

10

1 reference

12 August 2017

Peter L Collins

11

1 reference

12 August 2017

Verity C L Dowdell

12

1 reference

12 August 2017

Sally J Keegan

13

1 reference

12 August 2017

Richard D Kelsey

14

1 reference

12 August 2017

Michael J Lockyer

15

1 reference

12 August 2017

Cindy Luongo

16

1 reference

12 August 2017

Pilar Najarro

17

1 reference

12 August 2017

Raymond J Pickles

18

1 reference

12 August 2017

Mark Simmonds

19

1 reference

12 August 2017

Debbie Taylor

20

1 reference

12 August 2017

Stan Tyms

21

1 reference

12 August 2017

Lara J Wilson

22

1 reference

12 August 2017

Kenneth L Powell

23

1 reference

12 August 2017

language of work or name

English

0 references

publication date

18 June 2007

1 reference

Antimicrobial Agents and Chemotherapy

12 August 2017

1 reference

12 August 2017

51

1 reference

12 August 2017

9

1 reference

12 August 2017

3346-3353

1 reference

1,4-benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Crystal structure of the rabies virus nucleoprotein-RNA complex

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Structure of the vesicular stomatitis virus nucleoprotein-RNA complex

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

1,4-Benzodiazepines as inhibitors of respiratory syncytial virus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Respiratory syncytial virus infection in elderly and high-risk adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

New drugs and treatment for respiratory syncytial virus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Orally active fusion inhibitor of respiratory syncytial virus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Investigations into the amino-terminal domain of the respiratory syncytial virus nucleocapsid protein reveal elements important for nucleocapsid formation and interaction with the phosphoprotein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Mortality associated with influenza and respiratory syncytial virus in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Respiratory syncytial virus infection in adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Respiratory syncytial virus infection in children with congenital heart disease: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Effects of ribavirin on respiratory syncytial virus in vitro

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Prevention of infections with respiratory syncytial virus: the hopes and hurdles ahead

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043207

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17576833

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00211-07

1 reference

12 August 2017

1 reference

12 August 2017

1 reference